Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Michael Entzeroth"'
Autor:
Wolfgang H. B. Sauer
Publikováno v:
ChemMedChem. 2:243-244
Autor:
Andreas Link
Publikováno v:
Angewandte Chemie. 119:22-22
Autor:
Carl Kaiser
Publikováno v:
Journal of Medicinal Chemistry. 50:408-408
Autor:
Terence A. Kelly
Publikováno v:
Journal of the American Chemical Society. 128:17157-17157
Autor:
Carl Kaiser
Publikováno v:
Journal of Medicinal Chemistry; Jan2007, Vol. 50 Issue 2, p408-408, 1p
Autor:
Michael Entzeroth, Anil Kumar Ratty
Publikováno v:
Open Journal of Depression. :31-68
Over more than 60 years, monoamine oxidase (MAO) inhibitors are available for therapy of central nervous diseases. Although they have shown to be efficacious specifically in the treatment of major depressive disorders and treatment-resistant depressi
Autor:
Link, Andreas
Publikováno v:
Angewandte Chemie. International Edition; December 2006, Vol. 46 Issue: 1-2 p22-22, 1p
Autor:
Link, Andreas
Publikováno v:
Angewandte Chemie; December 2006, Vol. 119 Issue: 1-2 p22-22, 1p
Autor:
Hong Yan Song, Melvin Ng, Zou Yong, Eric T. Sun, Michael Entzeroth, Anders Poulsen, Dizhong Chen, Kee Chuan Goh, Joyce Wei Wei Chang, Kanda Sangthongpitag, Walter Stünkel, Niefang Yu, Zahid Bonday, Haishan Wang, Weiping Deng, Lye Pek Ling, Stéphanie Blanchard, Hwee Hoon Khng, Wai Chung Ong, Lijuan Fang, Xiaofeng Wu, Xukun Wang, Siok Kun Goh
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 19:1403-1408
A series of N-hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides were designed and synthesized as novel HDAC inhibitors. General SAR has been established for the substituents at positions 1 and 2, as well as the importance of the ethylene gro
Publikováno v:
Biotechnology Journal. 3:364-369
The Experimental Therapeutics Center (ETC) has been established at Biopolis to advance translational research by bridging the gap between discovery science and commercialization. We describe the Electronic Research Habitat at ETC, a comprehensive har